FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025276231> ?p ?o ?g. }

• W3025276231 endingPage "197" @default.
• W3025276231 startingPage "186" @default.
• W3025276231 abstract "Oral antibiotics have probable or documented therapeutic utility for multiple enteric conditions commonly treated by gastroenterologists and hepatologists, but they are not frequently prescribed. Barriers to antibiotic use include concerns about bacterial resistance, drug interactions, and antibiotic-associated side effects and toxicity, particularly in vulnerable populations. The use of minimally absorbed oral antibiotics has been suggested as an approach to overcoming some of these barriers, but minimally absorbed antibiotics have not been an important part of the US gastroenterologists' or hepatologists' armamentarium until recently. The 2004 introduction in the United States of the nonabsorbed (<0.4%) oral antibiotic rifaximin is cause for reassessing the potential usefulness of minimally absorbed oral antibiotics for bacterial enteric illness. Rifaximin has broad-spectrum in vitro antibacterial activity against enteric pathogens, gut-localized action, and minimal systemic absorption-a profile consistent with usefulness for a range of enteric conditions involving a pathogenetic role of bacteria. The emerging clinical profile of rifaximin also supports its potential utility for multiple enteric conditions. Rifaximin has a tolerability profile comparable to that of placebo and is not known to interact clinically with other medications. The efficacy of rifaximin is well documented for the treatment of infectious diarrhea caused by noninvasive pathogens and hepatic encephalopathy. A growing body of data supports the efficacy of rifaximin for additional enteric conditions, such as Crohn's disease, ulcerative colitis, small-intestinal bacterial overgrowth, pouchitis, and antibiotic-associated colitis, that are characterized by acute bacterial infection or bacterial colonization. In addition, rifaximin has recently been demonstrated effective in the prevention of travelers' diarrhea and shigellosis in controlled clinical studies. Ongoing studies and more experience with rifaximin in clinical practice will help to further define the role of this antibiotic in gastroenterology and hepatology." @default.
• W3025276231 created "2020-05-21" @default.
• W3025276231 creator A5020827915 @default.
• W3025276231 creator A5036594446 @default.
• W3025276231 creator A5044524314 @default.
• W3025276231 date "2006-03-01" @default.
• W3025276231 modified "2023-10-16" @default.
• W3025276231 title "Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology." @default.
• W3025276231 cites W119395284 @default.
• W3025276231 cites W137398571 @default.
• W3025276231 cites W1576640379 @default.
• W3025276231 cites W186157083 @default.
• W3025276231 cites W1891955096 @default.
• W3025276231 cites W1901984760 @default.
• W3025276231 cites W1972248676 @default.
• W3025276231 cites W1972667757 @default.
• W3025276231 cites W1980654894 @default.
• W3025276231 cites W1989307048 @default.
• W3025276231 cites W2005151284 @default.
• W3025276231 cites W2007435811 @default.
• W3025276231 cites W2008593985 @default.
• W3025276231 cites W2010459511 @default.
• W3025276231 cites W2016404251 @default.
• W3025276231 cites W2019183483 @default.
• W3025276231 cites W2025778359 @default.
• W3025276231 cites W2031132776 @default.
• W3025276231 cites W2033786691 @default.
• W3025276231 cites W2042474819 @default.
• W3025276231 cites W2045466789 @default.
• W3025276231 cites W2046866735 @default.
• W3025276231 cites W2047740672 @default.
• W3025276231 cites W2049779424 @default.
• W3025276231 cites W2055423211 @default.
• W3025276231 cites W2055761175 @default.
• W3025276231 cites W206022199 @default.
• W3025276231 cites W2068358138 @default.
• W3025276231 cites W2072791701 @default.
• W3025276231 cites W2082787452 @default.
• W3025276231 cites W2086025604 @default.
• W3025276231 cites W2088313490 @default.
• W3025276231 cites W2091756720 @default.
• W3025276231 cites W2100999850 @default.
• W3025276231 cites W2110028268 @default.
• W3025276231 cites W2133926562 @default.
• W3025276231 cites W2135051122 @default.
• W3025276231 cites W2138419487 @default.
• W3025276231 cites W2141397074 @default.
• W3025276231 cites W2150619022 @default.
• W3025276231 cites W2153996209 @default.
• W3025276231 cites W2165399037 @default.
• W3025276231 cites W2230236642 @default.
• W3025276231 cites W2408499544 @default.
• W3025276231 cites W2413815825 @default.
• W3025276231 cites W2431921421 @default.
• W3025276231 cites W2439491426 @default.
• W3025276231 cites W2466408471 @default.
• W3025276231 cites W264846215 @default.
• W3025276231 cites W30637582 @default.
• W3025276231 cites W34960532 @default.
• W3025276231 cites W40566378 @default.
• W3025276231 cites W70523712 @default.
• W3025276231 cites W74694173 @default.
• W3025276231 cites W82088966 @default.
• W3025276231 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5335639" @default.
• W3025276231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28286448" @default.
• W3025276231 hasPublicationYear "2006" @default.
• W3025276231 type Work @default.
• W3025276231 sameAs 3025276231 @default.
• W3025276231 citedByCount "4" @default.
• W3025276231 countsByYear W30252762312020 @default.
• W3025276231 countsByYear W30252762312023 @default.
• W3025276231 crossrefType "journal-article" @default.
• W3025276231 hasAuthorship W3025276231A5020827915 @default.
• W3025276231 hasAuthorship W3025276231A5036594446 @default.
• W3025276231 hasAuthorship W3025276231A5044524314 @default.
• W3025276231 hasConcept C126322002 @default.
• W3025276231 hasConcept C197934379 @default.
• W3025276231 hasConcept C2778271842 @default.
• W3025276231 hasConcept C2778375690 @default.
• W3025276231 hasConcept C2778889925 @default.
• W3025276231 hasConcept C2779134260 @default.
• W3025276231 hasConcept C2780479503 @default.
• W3025276231 hasConcept C2780999109 @default.
• W3025276231 hasConcept C41260117 @default.
• W3025276231 hasConcept C501593827 @default.
• W3025276231 hasConcept C71924100 @default.
• W3025276231 hasConcept C86803240 @default.
• W3025276231 hasConcept C89423630 @default.
• W3025276231 hasConcept C90924648 @default.
• W3025276231 hasConceptScore W3025276231C126322002 @default.
• W3025276231 hasConceptScore W3025276231C197934379 @default.
• W3025276231 hasConceptScore W3025276231C2778271842 @default.
• W3025276231 hasConceptScore W3025276231C2778375690 @default.
• W3025276231 hasConceptScore W3025276231C2778889925 @default.
• W3025276231 hasConceptScore W3025276231C2779134260 @default.
• W3025276231 hasConceptScore W3025276231C2780479503 @default.
• W3025276231 hasConceptScore W3025276231C2780999109 @default.
• W3025276231 hasConceptScore W3025276231C41260117 @default.

• next